RACHEL WATTS: Open Payments
NPI 1992302699 · NORTH AUGUSTA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 16 payments from 10 companies in 2025. Trend: 2023 $791 · 2024 $495 · 2025 $279
Food & beverage: $279
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $48 |
| Novo Nordisk Inc | 2 | $33 |
| Exact Sciences Corporation | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| PFIZER INC. | 2 | $27 |
| Edwards Lifesciences Corporation | 1 | $26 |
| Lilly USA, LLC | 1 | $26 |
| Boston Scientific Corporation | 1 | $26 |
| Corcept Therapeutics | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
Products named: TRELEGY ELLIPTA, SAPIEN 3 Ultra RESILIA, JARDIANCE, Spectra WaveWriter, Ozempic, Cologuard Collection Kit, Korlym, SHINGRIX.
Industry payments across SC — which companies pay providers there.
